TABLE 4.
Control | Walnut | SEM | P | |
---|---|---|---|---|
Cholesterol, mg/dL | 194 | 187 | 7.1 | 0.03 |
LDL cholesterol, mg/dL | 117 | 108 | 6.5 | <0.01 |
HDL cholesterol, mg/dL | 48.0 | 48.5 | 3.0 | 0.51 |
TGs, mg/dL | 92.4 | 89.8 | 8.2 | 0.35 |
Glucose, mg/dL | 99.7 | 99.5 | 1.6 | 0.79 |
IL-6, pg/mL | 1.43 | 1.36 | 0.18 | 0.32 |
CRP, ng/mL | 3330 | 3830 | 1290 | 0.37 |
SAA, ng/mL | 5490 | 6104 | 2790 | 0.52 |
sICAM, ng/mL | 336 | 334 | 16.4 | 0.68 |
sVCAM, ng/mL | 503 | 502 | 32.6 | 0.86 |
1Values are least-square means ± pooled SEMs; n = 18 participants in a crossover design. Treatment effects were evaluated with the use of a mixed-model ANOVA. CRP, C-reactive protein; SAA, serum amyloid A; sICAM, soluble intercellular adhesion molecule; sVCAM, soluble vascular cell adhesion molecule.